Citigroup
HELP

Citigroup’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Citigroup’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2K Sell
1,847
-4,105
-69% -$20.5K ﹤0.01% 5217
2026
Q1 		$28.7K Buy
+5,952
New +$38.5K ﹤0.01% 4718
2023
Q1 		– Sell
-2
Closed -$26 – 5564
2022
Q4 		$26 Hold
2
– – ﹤0.01% 5692
2022
Q3 		$0 Hold
2
– – ﹤0.01% 5912
2022
Q2 		$0 Sell
2
-40
-95% -$969 ﹤0.01% 6299
2022
Q1 		$1K Buy
+42
New +$1.53K ﹤0.01% 6151

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Citigroup's HELP Position: Q2 2026 in Review

Citigroup reduced its Helus Pharma Inc. Common Stock (HELP) stake by 69% in Q2 2026, selling an estimated $20.5K and leaving 1,847 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5217.

Citigroup first reported a position in HELP in Q1 2022 and has held it in 6 quarters since. The position peaked at $28.7K in Q1 2026. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Citigroup held 1,847 shares of Helus Pharma Inc. Common Stock worth $12.2K as of Q2 2026.
  • Citigroup sold 4,105 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $20.5K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5217 holding.
  • Citigroup first reported a position in Helus Pharma Inc. Common Stock in Q1 2022 and has held it in 6 quarters since.
  • Citigroup's Helus Pharma Inc. Common Stock position peaked at $28.7K in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.